-
5-Azacytidine: Reliable Assay Design
2026-08-24
Learn how 5-Azacytidine (SKU A1907) can support reproducible viability, proliferation, and cytotoxicity workflows through mechanism-aware dosing, solvent control, and orthogonal readouts. This scenario-driven guide connects DNA methyltransferase inhibition with practical assay optimization and interpretation.
-
Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-08-24
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for measuring 12 purine ribonucleosides, including 10 methylated species such as 1-methyl Adenosine. Ammonium bicarbonate-assisted ionization, chromatographic isomer resolution, and methanol–SPE cleanup improved sensitivity sufficiently for intracellular measurements, creating a practical foundation for RNA modification research and nucleoside biomarker discovery.
-
(S)-(+)-Dimethindene maleate: M2 Workflow
2026-08-23
This practical guide explains how to use (S)-(+)-Dimethindene maleate as a research reagent for M2 muscarinic receptor antagonism while accounting for its additional H1 histamine receptor activity. It supports receptor-signaling, autonomic regulation, cardiovascular physiology, and respiratory studies, but it is not intended for diagnostic, therapeutic, or medical use.
-
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-22
A 2024 study found that Moxidectin potentiates amphotericin B and nystatin against Candida albicans by increasing ergosterol biosynthesis, thereby strengthening polyene engagement with the fungal membrane. Genetic, biochemical, and mouse-model data support this repurposing strategy, while translational questions about exposure, safety, and clinical dosing remain open.
-
Proliferation Tracing Models Breast Cancer Relapse
2026-08-22
The reference study developed a dual recombinase PyMT mouse model that traces and ablates recently proliferating tumor cells, producing regression followed by relapse from residual low-cycling populations. Single-cell RNA sequencing showed that recurrent tumors were enriched for cancer stem cells, protumor γδ T cells, and myeloid programs associated with poor therapeutic response, establishing a useful platform for relapse biology and treatment testing.
-
Syringin: Interpreting RCC Assay Evidence
2026-08-21
Syringin natural product research is moving beyond single-endpoint screening. This article explains how the RCC evidence connects EGFR/PI3K/Akt signaling, sunitinib response, apoptosis, and orthogonal assay design while clarifying material provenance and experimental limitations.
-
FGFR1 as a Druggable Target in Schizophrenia
2026-08-20
A 2025 Molecular Neurobiology study integrated druggable-gene resources, schizophrenia GWAS data, Mendelian randomization, colocalization, SMR, phenome-wide analysis, and molecular docking to prioritize therapeutic candidates. FGFR1 emerged as the most compelling target among six associated genes, although the findings remain a genetically supported hypothesis requiring functional and clinical validation.
-
Genistein A2198: Reliable Cell Assays
2026-08-20
Genistein (SKU A2198) offers a data-guided way to investigate growth-factor signaling, cell proliferation inhibition, and cytotoxicity without confusing pathway suppression with nonspecific cell death. This scenario-based guide covers solvent compatibility, dose selection, assay interpretation, mechanistic controls, and practical product selection.
-
Prednisolone: From GR Signaling to Translational Strategy
2026-08-19
Prednisolone is more than a standard synthetic glucocorticoid control: it can serve as a mechanistic anchor for connecting glucocorticoid receptor biology, inflammation modulation, and emerging targeted protein degradation strategies. This article outlines how translational researchers can use Prednisolone rigorously while distinguishing established receptor pharmacology from the newer ERAD-engaging chimera platform reported for desonide.
-
4-Hydroxytamoxifen: Practical Protocol & QC Guide
2026-08-19
This guide explains how to prepare, control, and apply 4-Hydroxytamoxifen (SKU B6167) in DMSO-compatible estrogen receptor studies, including cancer and cardiac myocyte workflows. It is not appropriate for protocols that require water- or ethanol-based solubility unless a separate formulation has been validated.
-
Self-Assembling EVMPs for Extrahepatic mRNA Delivery
2026-08-18
The reference study presents a bottom-up enveloped virus-mimicking particle that combines a self-assembling peptide with tunable phospholipid envelopes to direct mRNA beyond the liver. Its optimized lung-targeted formulation reached substantial endothelial and immune-cell transfection and suppressed metastatic lung tumors when carrying IL-12 mRNA, while retaining potential for repeat administration.
-
D-Luciferin Sodium Salt in CAR-Macrophage Assays
2026-08-18
D-Luciferin sodium salt enables quantitative firefly luciferase readouts for studying CAR-macrophage biology, cellular energy metabolism, and tumor–immune interactions. This article connects substrate chemistry with the mRNA-LNP CAR-M strategy reported by Gu et al., emphasizing assay design, interpretation, and translational limitations.
-
How p38α Inhibitors Tune Dephosphorylation
2026-08-17
The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can also accelerate WIP1-mediated dephosphorylation by exposing the activation-loop phospho-threonine. Biochemical analysis and X-ray structures support a dual-action model that may guide the design of more selective p38α MAPK inhibitors.
-
Bobcat339 and the Epigenetic Logic of Osteogenesis
2026-08-17
A translational perspective on using Bobcat339 to interrogate TET-dependent DNA demethylation, super-enhancer redistribution, and osteogenic failure in senile osteoporosis research.
-
Zoledronic Acid: Reliable Cell Assay Workflows
2026-08-16
This scenario-driven guide shows how Zoledronic Acid (SKU A1352) can support more interpretable viability, proliferation, and apoptosis experiments. It covers formulation constraints, dose–time design, endpoint validation, data interpretation, and practical product-selection criteria for cancer and bone disease research.